ErbB-2 expression and its association with other biological parameters of breast cancer among Indian women

Indian Journal of Cancer

Volumn 47, Issue 1, 2010, Pages 8-15

  Vaidyanathan, K ^a   Kumar, P ^b   Reddy, C O ^b   Deshmane, V ^b   Somasundaram, K ^a   Mukherjee, G ^b  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

Breast cancer ErbB 2; Genomic polymerase chain reaction; Immunohistochemistry

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDIA; INTRADUCTAL CARCINOMA; LYMPH NODE; ONCOGENE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; FEMALE; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; INDIA; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTOR, ERBB-2;

EID: 75749129452     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.58852     Document Type: Article

References (33)

1. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N et al. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature 1986;319: 230-234 (Pubitemid 16128786)
2. Bargmann CI, Hung MC, Wienberg RA. The neu oncogene encodes an epidermal growth factor receptor related protein. Nature 1986;319: 226-230
3. Fukushige S, Matsubara K, Yoshida M, Sasaki M, Suzuki T, Semba K et al. Localization of a novel v erbB related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol Cell Biol 1986;6:955-958
4. Ullrich A, Schlesinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-212
5. Woods Ignatoski KM, Livant DL, Markwart S, Grewal NK, Ethier SP. The role of phosphatidylinositol 3'-kinase and its downstream signals in erbB-2 mediated transformation. Mol Cancer Res 2003;1:551-560
6. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE et al. Studies of the HER-2/neu proto oncogene in human breast and ovarian cancer. Science 1989; 244: 707-712
7. Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaronson SA. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 1987;237:178-182
8. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-182
9. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER-2. N Engl J Med 2001;344:783-792
10. Allred DC, Clark GM, Tandon AK, Molina R, Tormey DC, Osborne CK et al. HER-2/neu in node- negative breast cancer: prognostic significance of over expression infl uenced by the presence of in situ carcinoma. J Clin Oncol 1992;10:599-605.
11. Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Save-Soderborgh J, Anbazhagan R et al. Prognostic importance of c-erbB-2 expression in breast cancer International (Ludwig) Breast Cancer Study Group. J Clin Oncol 1992;10:1049-1056
12. Zafrani B, Aubriot MH, Mouret E, De Crémoux P, De Rycke Y, Nicolas A et al. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases. Histopathology 2001; 38: 271-274
13. Sastre-Garau X, Jouve M, Asselain B, Vincent - Salomon A, Beuzboc P, Dorval T et al Infiltrating lobular carcinoma of the breast; clinico-pathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996;77:113-120
14. Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z et al. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor positive primary breast cancer. J Natl Cancer Inst 2003;95:142-153 (Pubitemid 36193263)
15. Vernimmen D, Gueders M, Pisvin S, Delvenne P, Winkler R. Different mechanisms are implicated in ErbB-2 gene over expression in breast and in other cancers. Br J Cancer 2003;89:899-906.
16. Konigshoff M, Wilhelm J, Bohle RM, Pingoud A, Hahn M. HER-2/neu gene copy number quantified by real-time PCR: Comparison of gene amplification, heterozygosity and immunohistochemical status in breast cancer tissue. Clin Chem 2003;49: 219-229
17. Pellikainen J, Naukkarinen A, Ropponen K, Rummukainen J, Kataja V, Kellokoski J et al. Expression of HER-2 and its association with AP-2 in breast cancer. Eur J Cancer 2004;40:1485-1495
18. Ray A, Sharma BK, Kaur S, Sharma S, Sharma JK. Overexpression of c-erbB-2 oncoprotein and associated pathobiological factors in invasive primary breast cancer. Indian J Exp Biol 2004;42:253-258
19. Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Chikhlikar PR et al. Prognostic Significance of Immunohistochemically Localized Biomarkers in Stage II and Stage III Breast Cancer: A Multivariate Analysis. Ann Surg Oncol 2000;7:305-311
20. Querzoli P, Marchetti E, Fabris G, Marzola A, Ferretti S, Iacobelli S et al. Immunohistochemical expression of c-erbB-2 in human breast cancer by monoclonal antibody: correlation with lymph node and ER status. Tumori 1990;76:461-464
21. Tiwari RK, Borgen PI, Wong GY, Cordon-Cardo C, Osborne MP. HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis. Anticancer Res 1992;12:419-425
22. Gullick WJ, Love SB, Wright C, Barnes DM, Gusterson B, Harris AL et al. C-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 1991;63:434-438
23. Ivkovic-Kapicl T, Knezevic-Usaj S, Djilas-Ivanovic D, Panjkovic M. Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer. In vivo 2007;21:673-678 (Pubitemid 47232671)
24. Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Breast J 2005;11:278-280
25. Marx D, Schauer A, Reiche C, May A, Ummenhofer L, Reles A et al. c-erbB-2 expression in correlation to other biological parameters of breast cancer. J Cancer Res Clin Oncol 1990;116:15-20.
26. Guerin M, Barrois M, Terrier MJ, Spielman M ,Riou G. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res 1988;3:21-31.
27. Shackney SE, Smith CA, Pollice A, Brown K, Day R, Julian T et al. Intracellular patterns of Her-2/neu, ras and ploidy abnormalities in primary breast cancers predict postoperative clinical disease-free survival. Clin Cancer Res 2004;10:3042-3052
28. Nieto Y, Nawaz S, Shpall EJ, Bearman SI, Murphy J, Jones RB. Longterm analysis and prospective validation of a prognostic model for patients with high-risk primary breast cancer receiving high-dose chemotherapy. Clin Cancer Res 2004;10:2609-2617 (Pubitemid 38509133)
29. Schnitt SJ. Traditional and newer pathologic factors. J Natl Cancer Inst Monogr 2001;30:22-26
30. International Union against Cancer, UICC. TNM classification of malignant tumors 6th ed. New York: John Wiley and Sons; 2002.
31. The American Joint Committee on Cancer (AJCC). AJCC Cancer staging manual 6th ed. New York: Springer Verlag; 2002.
32. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: 1. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathology 1991;19:403-410
33. Tavarish FA, Devilee P. World Health Organization Classification of tumors. Pathology and Genetics. Tumors of breast and female genital tract. Lyon : IARC Press; 2003.